Athina Ludovica Van Gasse

Athina Ludovica Van Gasse

Auto-generated profile, based on publicly available information

Athina Ludovica Van Gasse

Department of Immunology, Allergology and Rheumatology and the Infla-Med Centre of Excellence, University Antwerp, Antwerp University Hospital, Antwerpen, Belgium

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2017 in Allergy
Verified
Journal Article
Closed access
PDF file
AGA. L. Van Gasse
A. L. Van Gasse
VSV. Sabato
V. Sabato
AUA. P. Uyttebroek
A. P. Uyttebroek
JEJ. Elst
J. Elst
MFM. A. Faber
M. A. Faber
DED. G. Ebo
D. G. Ebo

1 March 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
AGAthina L. Van Gasse
Athina L. Van Gasse
JEJessy Elst
Jessy Elst
CBChris H. Bridts
Chris H. Bridts
CMChristel Mertens
Christel Mertens
MFMargaretha Faber
Margaretha Faber
DEDidier G. Ebo
Didier G. Ebo

30 May 2018 in Allergy
Verified
Journal Article
Closed access
PDF file
IDI. I. Decuyper
I. I. Decuyper
MFM. A. Faber
M. A. Faber
HLH. Lapeere
H. Lapeere
CMC. Mertens
C. Mertens
HRHans-Peter Rihs
Hans-Peter Rihs
DED. G. Ebo
D. G. Ebo

13 February 2022 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
JEJessy Elst
Jessy Elst
MPMarie‐Line M. van der Poorten
Marie‐Line M. van der Poorten
AGAthina L. Van Gasse
Athina L. Van Gasse
CMChristel Mertens
Christel Mertens
MHMargo M. Hagendorens
Margo M. Hagendorens
VSVito Sabato
Vito Sabato

7 April 2022 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
DEDidier G. Ebo
Didier G. Ebo
JEJessy Elst
Jessy Elst
NMNele Moonen
Nele Moonen
MPMarie‐Line M. van der Poorten
Marie‐Line M. van der Poorten
AGAthina L. Van Gasse
Athina L. Van Gasse
VSVito Sabato
Vito Sabato

1 January 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
DEDidier G. Ebo
Didier G. Ebo
MBMichiel Beyens
Michiel Beyens
KHKevin Heremans
Kevin Heremans
MPMarie-Line M. van der Poorten
Marie-Line M. van der Poorten
AGAthina L. Van Gasse
Athina L. Van Gasse
JEJessy Elst
Jessy Elst
Immediate hypersensitivity reactions can pose a clinical and diagnostic challenge, mainly because of the multifarious clinical presentation and distinct underlying – frequently uncertain – mechanisms. Anaphylaxis encompasses all rapidly developing and life-threatening signs and may cause death. Evidence has accumulated that immediate hypersensitivity and anaphylaxis do not necessarily involve an allergen-specific immune response with cross-linking of specific IgE (sIgE) antibodies bound to their high-affinity IgE receptor (FcεRI) on the surface of mast cells (MCs) and basophils. Immediate hypersensitive and anaphylaxis can also result from alternative specific and nonspecific MC and basophils activation and degranulation, such as complementderived anaphylatoxins and off-target occupancy of MC and/or basophil surface receptors such as the Masrelated G protein-coupled receptor X2 (MRGPRX2). Degranulation of MCs and basophils results in the release of inflammatory mediators, which can be, depending on the underlying trigger, in a different spatiotemporal manner. In addition, hypersensitivity and anaphylaxis can occur entirely independently of MC and basophil degranulation, as observed in hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) that divert normal arachidonic acid metabolism by inhibiting the cyclooxygenase (COX)-1 isoenzyme. Finally, one should remember that anaphylaxis might be part of the phenotype of particular - sometimes poorly recognizable - conditions such as clonal MC diseases (e.g. mastocytosis) and MC activation syndrome (MCAS). This review provides a status update on the molecular mechanisms involved in both sIgE/FcεRI- and non-sIgE/FcεRIdependent immediate hypersensitivity and anaphylaxis. In conclusion, there is increasing evidence for alternative pathophysiological hypersensitivity and anaphylaxis endotypes that are phenotypically and biologically indistinguishable, which are frequently difficult to diagnose, mainly because of uncertainties associated with diagnostic tests that might not enable to unveil the underlying mechanism.